Filing Details

Accession Number:
0001415889-22-007064
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-29 21:00:18
Reporting Period:
2022-06-27
Accepted Time:
2022-06-29 21:00:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133869 Capricor Therapeutics Inc. CAPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1310611 B David Musket C/O Capricor Therapeutics, Inc.
10865 Road To The Cure, Suite 150
San Diego CA 92121
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-06-27 17,775 $4.44 40,962 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,096 Indirect Held by Reporting Person's IRA
Footnotes
  1. The sale reported on this Form 4 represents shares sold by the Reporting Person to partially cover tax obligations in connection to stock holdings.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.46, inclusive. The reporting person undertakes to provide to Capricor Therapeutics, Inc., any security holder of Capricor Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.